HB 1638 Pennsylvania House · 2025-2026 Regular Session

An Act ensuring reproductive freedom by preserving the anonymity of providers on prescription labels.

HB 1638 requires pharmacies and dispensers to display a provider's healthcare practice name instead of their personal name on prescription labels for mifepristone, misoprostol, or their generic alternatives. This applies to any licensed provider (including physicians or prescribers) who requests this change for reproductive medication prescriptions. The law mandates that dispensers comply with such requests, effectively shielding the provider's identity on the label. It takes effect 30 days after enactment.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
Governor
Introduced Jun 23, 2025 Last action Jun 23, 2025